UNH vs SOLV
By Alex · Tickerpine
UnitedHealth Group Incorporated vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | UNH | SOLV |
|---|---|---|
| Price | $427.89 | $79.53 |
| Market cap | $388.59B | $13.77B |
| P/E ratio | 32.3 | 9.7 |
| ROE | 12.18% | 34.79% |
| Profit margin | 2.68% | 17.33% |
| Revenue growth | 2.00% | -3.00% |
| Dividend yield | 2.17% | — |
| Beta | 0.65 | 0.75 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
UNH vs SOLV in plain English
- UNH is the bigger company — about 28.2× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 9.7 vs 32.3).
- SOLV earns a higher return on equity (35% vs 12%).
- UNH is growing revenue faster (2% vs -3%).
- UNH pays a dividend (2.17%) while the other effectively doesn't.
How would $1,000 have done in each?
UNH return calculator
See what $1,000 in UnitedHealth Group Incorporated would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.